Literature DB >> 15479994

Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction.

Madelon Y Bolling1, Robert J Kohlenberg.   

Abstract

BACKGROUND: The goal of this study was to document the existence of psychological side effects associated with serotonin reuptake inhibitors (SSRIs) taken for depression and to determine their relationship to patients' decisions to stop treatment, and attitudes toward taking SSRIs again.
METHOD: We conducted 161 semi-structured telephone interviews of adults who had completed a course of treatment for depression with one of the SSRIs. We identified 29 categories of unwanted psychological effects and analyzed data in terms of responders and non-responders, the former split into those who would, and those who would not take the same drug again if depressed in the future ('take-again responders' and 'not-again responders', respectively).
RESULTS: Psychological side effects were cited just as often as physical side effects as the primary reason for quitting SSRI treatment. Non-responders cited psychological side effects rather than non-response as the primary reason for quitting, and not-again responders cited physical more than psychological side effects. Not-again responders and non-responders did not differ in the number of side effects experienced, and non-responders experienced significantly more unwanted psychological effects than either type of responder (chi2= 6.767, p=0.009).
CONCLUSION: Psychological side effects might well be included in measures and discussions of side effects, even though they present no known physical danger to the patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479994     DOI: 10.1159/000080392

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  15 in total

1.  Antidepressants: misnamed and misrepresented.

Authors:  Joanna Moncrieff
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Managing depression in primary care: achieving remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

3.  Apathy in late-life depression: common, persistent, and disabling.

Authors:  Genevieve S Yuen; Saumya Bhutani; Bryony J Lucas; Faith M Gunning; Bassem AbdelMalak; Joanna K Seirup; Sibel A Klimstra; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2014-06-26       Impact factor: 4.105

4.  SSRI-Induced Indifference.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2010-10

5.  Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.

Authors:  Donatella Marazziti; Federico Mucci; Beniamino Tripodi; Manuel Glauco Carbone; Alessia Muscarella; Valentina Falaschi; Stefano Baroni
Journal:  Clin Neuropsychiatry       Date:  2019-04

6.  Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response.

Authors:  Genevieve S Yuen; Faith M Gunning; Eric Woods; Sibel A Klimstra; Matthew J Hoptman; George S Alexopoulos
Journal:  J Affect Disord       Date:  2014-05-22       Impact factor: 4.839

Review 7.  Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management.

Authors:  Helia Ghanean; Amanda K Ceniti; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

8.  Aripiprazole for Treatment of Apathy.

Authors:  Varun Monga; Prasad R Padala
Journal:  Innov Clin Neurosci       Date:  2015 Sep-Oct

Review 9.  Core symptoms of major depressive disorder: relevance to diagnosis and treatment.

Authors:  Sidney H Kennedy
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 10.  The role of cognitive dysfunction in the symptoms and remission from depression.

Authors:  Xenia Gonda; Maurizio Pompili; Gianluca Serafini; Andre F Carvalho; Zoltan Rihmer; Peter Dome
Journal:  Ann Gen Psychiatry       Date:  2015-09-22       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.